Asset Manager

Updated:

International Flavors & Fragrances

Erik Fyrwald leads IFF, the 190-year-old taste and scent ingredient maker that generates over $11B in annual revenue.

International Flavors & Fragrances

International Flavors & Fragrances was formed through a series of mergers, most notably the 1958 combination of Polak & Schwarz and van Ameringen-Haebler, two early-20th-century Dutch and American flavor and fragrance houses. The company has expanded well beyond its fragrance origins, most dramatically with the 2021 merger with DuPont's Nutrition & Biosciences unit (per the firm, 2021). That deal added a broad portfolio of food enzymes, cultures, and texturants to IFF's existing scent and taste business, creating an ingredient colossus serving food, beverage, home care, and personal care manufacturers globally. IFF's strategy rests on direct sales of compounded flavors, fragrance oils, and specialty ingredients to large consumer packaged goods companies. The portfolio spans four segments: Nourish (food ingredients and flavors), Health & Biosciences (enzymes, probiotics, home and personal care), Scent (fine fragrances and consumer scents), and Pharma Solutions (excipients and coatings). Geographic revenue is distributed across North America, Europe, Africa/Middle East, and Asia, with meaningful exposure to emerging markets. The firm's R&D pipeline, which includes molecules like the sustainably sourced captive lavender Heart Scent, is central to its value proposition. Production and application labs operate in dozens of countries, supporting local manufacturing partnerships. Publicly listed on the NYSE under the symbol IFF, the company employs more than 20,000 people across research, manufacturing, and commercial operations. The DuPont N&B acquisition was transformative but also loaded the balance sheet with debt; management has since pursued a multi-year divestiture and deleveraging plan. In February 2025, IFF announced the sale of its Pharma Solutions business to Roquette for up to $2.85 billion (per IFF press release, 2025), a deal designed to sharpen the portfolio around taste, scent, and health. Additional offices include major sites in Hilversum (Netherlands) and Wilmington (Delaware). IFF's structural differentiator is the intellectual property embedded in its library of flavor and fragrance molecules — a catalog built over 190 years that is not replicable by a startup. The business model hybridizes specialty chemicals with creative artistry, requiring both a deep bench of flavorists and perfumers trained over decades and an industrial-scale manufacturing network. This dual dependence on creative talent and capital-intensive production creates a barrier to entry that explains why the industry remains concentrated among four key players.

Website
iff.com

General information

Firm type

Asset Manager

Year founded

1833

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Principals

Erik Fyrwald

Chief Executive Officer

Sector focus

Food & BeverageConsumer GoodsHealth & Wellness

Frequently asked questions

What does International Flavors & Fragrances actually produce?

IFF manufactures compounded flavors for foods and beverages, fragrance oils and encapsulates for perfumes and consumer goods, and specialty ingredients including enzymes, probiotics, and texturants. Its products go into finished goods sold by Nestlé, Unilever, Estée Lauder, and thousands of other brands. The firm also offers pharmaceutical excipients, though that division was sold in 2025.

How did IFF become a player in food ingredients beyond flavors?

The company's scope expanded dramatically through the 2021 merger with DuPont's Nutrition & Biosciences unit. That deal brought IFF a large portfolio of food enzymes, soy proteins, cultures for dairy, and hydrocolloids, effectively doubling the company's size and adding deep fermentation and biotechnology capabilities. Before that, IFF was primarily known as a flavor and fragrance house.

Is IFF structured as a family office or does it invest third-party capital?

IFF is neither a family office nor an investment fund. It is a publicly traded operating company listed on the NYSE. It generates revenue from selling ingredients and does not manage capital for outside investors. Any family-office comparison would be incorrect; the firm's origin lies in two entrepreneurial flavor families merging in 1958.

What is IFF's geographic and operational footprint?

IFF operates research and creative centers, manufacturing plants, and application labs across North America, Europe, Asia, Africa, and the Middle East. Its headquarters are in New York City, with major innovation hubs in the Netherlands and Delaware. The firm serves a global customer base, with emerging markets contributing a growing share of sales.

What is the significance of IFF's 'molecule library'?

Over nearly two centuries, IFF has built a proprietary catalog of thousands of flavor and fragrance molecules, many protected by patents. Some, like captive or patent-protected synthetics, cannot be used by competitors. This library, combined with the firm's trained flavorists and perfumers, creates a long-term competitive advantage that new entrants cannot easily replicate.

Why did IFF sell the Pharma Solutions unit?

The sale of Pharma Solutions to Roquette, announced in February 2025, was part of a deleveraging plan following the DuPont N&B acquisition. IFF's management framed the divestiture as a portfolio-sharpening move, allowing the company to focus on its core taste, scent, and health-and-biosciences businesses. The deal is expected to close in the first half of 2025.

Who are IFF's main competitors?

The global flavor and fragrance industry remains concentrated among four major players: IFF, Givaudan, Symrise, and Firmenich (which merged with DSM to become dsm-firmenich in 2023). These four firms together control a large share of the market, competing on R&D, proprietary molecules, creative talent, and long-term customer relationships rather than purely on price.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo